Time to act on diabetes mellitus prevention in the West Bank, oPt: Current and future direct cost of diabetes and its complications

Abu-Rmeileh, Niveen M E; Ghandour, Rula; Mataria, Awad; Awawda, Sameera; Jabr, Samer; O’Flaherty, Martı́n

doi:10.1016/j.obmed.2017.04.001

Cited by 4 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3 Eventually, this translates into an immense impact on the government in terms of finance and human resources in disease treatment and the management of complications. 60 , 61 DRPs are common among patients with a complex medication regimen, especially those with multiple co-morbidities such as dyslipidemia, hypertension, and cardiovascular disease. 62 Interventions can be taken in accordance with the identified DRPs (i.e.…”

Section: Discussionmentioning

confidence: 99%

The Evaluation of home medication review for patients with type 2 diabetes mellitus by community pharmacists: a randomised controlled trial

Rosli¹,

Neoh²,

Wu³

et al. 2021

Pharm Pract (Granada)

View full text Add to dashboard Cite

Background: Successful diabetes treatment requires commitment and understanding of disease management by the patients. Objective: This trial aimed to evaluate the programme effectiveness of home medication review by community pharmacists (HMR-CP) in optimising diabetes care and reducing medication wastage. Methods: A randomised controlled trial was conducted on 166 patients with Type 2 Diabetes Mellitus (T2DM) who were randomly assigned to the intervention or control groups. The intervention group received HMR-CP at 0-month, 3-month, and 6-month. The primary outcome was haemoglobin A1c (HbA1c) while clinical outcomes, anthropometric data, and humanistic outcomes were the secondary outcomes. For the intervention group, drug-related problems (DRP) were classified according to the Pharmaceutical Care Network Europe Foundation (PCNE). Medication adherence was determined based on the Pill Counting Adherence Ratio (PCAR). The cost of medication wastage was calculated based on the total missed dose by the T2DM patients multiplied by the cost of medication. General linear model and generalised estimating equations were used to compare data across the different time-points within and between the groups, respectively. Results: No significant difference was observed in the demographic and anthropometric data at baseline between the two groups except for fasting blood glucose (FBG). There was a significant reduction in the HbA1c (-0.91%) and FBG (-1.62mmol/L) over the study period (p<0.05). A similar observation was noted in diastolic blood pressure (DBP) and total cholesterol (TC) but not in high-density lipoprotein (HDL), and anthropometric parameters. Both utility value and Michigan Diabetes Knowledge Test (MDKT) scores increased significantly over time. As for the intervention group, significant changes in PCAR (p<0.001) and the number of DRP (p<0.001) were noted. Conclusions: HMR-CP significantly improved the glycaemic control, QoL, medication adherence, and knowledge of T2DM patients as well as reduced the number of DRP and cost of medication wastage. However, the impact of HMR-CP on certain clinical and anthropometric parameters remains inconclusive and further investigation is warranted.

show abstract

Section: Discussionmentioning

confidence: 99%

The Evaluation of home medication review for patients with type 2 diabetes mellitus by community pharmacists: a randomised controlled trial

Rosli¹,

Neoh²,

Wu³

et al. 2021

Pharm Pract (Granada)

View full text Add to dashboard Cite

show abstract

“…7 Nevertheless, evidence indicates prevention of the disease progression, specifically the type II DM, is modestly achievable; and accessible and affordable health care for any DM type significantly decreases the negative effects too. 8,9 For example, proper management of diabetes mellitus reduces admission rates, health-care costs, and premature death rates, and increases productivity, and improves the quality of life. 2 However, in order to achieve the desirable diabetes management goals, cost-effective and ongoing clinical care, preventive practices, and person-centered goal setting and its implementation are more effective than managing the disease and its complications.…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The Magnitude, Types, and Roles of Social Support in Diabetes Management among Diabetics’ in Southern Ethiopia: a Multilevel, Multicenter Cross-Sectional Study

Jaafaripooyan

Habebo

Mosadeghrad

et al. 2021

DMSO

View full text Add to dashboard Cite

Introduction:Lifelong medical management is the main intervention to reduce diabetesrelated morbidities and premature deaths; yet, social support can be a vital intervention to improve diabetics' health. Therefore, this study aimed to determine the magnitude, types, and role of social support in diabetes management in southern Ethiopia. Methods: A multi-stage systematic sampling was applied to recruit 634 adult diabetics from the three-tiered healthcare system in the region. We proportionally distributed the sample size between randomly selected ten health-care facilities across the hierarchy. Pretested questionnaires and checklist; Epi-Info, and SPSS software used for data collection; entry, and analyses, respectively, and the statistical significance was determined at a P-value ≤0.05. Results: A total of 240 females and 356 males completed the study, and the overall magnitude of the social support was 50.20% [95% CI: 46.19%, 54.21%], and it was categorized into non-material and material with 44.13% [95% CI: 40.14%, 48.12%] and 34.23% [95% CI: 30.42%, 38.04%] magnitudes, respectively, and social support was left to the patients' families and friends whereas formal institutions and the public sectors were rarely offering when the patients needed it. Though sex, educational level, and health-care hierarchy were not significantly associated with the social support, residence, some occupations, presence of diabetic family members, acute medical conditions, blood glucose level, compliance to medical follow-ups, treatment adherence, and taking anti-diabetic drugs a day before the current visit to health-care facility were all statistically significantly associated with social support. Conclusion: One of every two adult diabetic patients in southern Ethiopia was receiving any social support, and social support for diabetic people reduces medical follow-ups absenteeism, improves treatment adherence, glycemic level controlling, and helps lifestyle modifications. Therefore, to keep diabetic people healthy and achieve diabetes management goals, the Ethiopian healthcare system, institutions, and concerned stakeholders should strengthen the social support for diabetic patients.

show abstract

Hypomagnesemia and Poor Glycemic Control among Type 2 Diabetic Patients: A Cross-Sectional Study

Nazzal¹,

Hamarshih²,

Hamshari³

et al. 2022

Indian Journal of Endocrinology and Metabolism

View full text Add to dashboard Cite

Background/Aim: Hypomagnesaemia has been shown to have a significant impact on both glycaemic control and diabetes complications in type 2 diabetes mellitus (T2DM) patients. This study aims to assess the prevalence of hypomagnesaemia in T2DM patients and find the association between serum magnesium levels and outcomes relevant to glycaemic control and diabetic complications in primary care unit. Methods: A cross-sectional study was conducted and included 373 patients (222 males and 151 females) from primary care unit. Serum magnesium levels were measured by the colorimetric endpoint method using the Cobas C501 system. Hypomagnesaemia was determined to be a serum magnesium level <1.6 mg/dL. In addition, the following data was also obtained: patients’ characteristics, anthropometric measurements, smoking status, HbA1c, comorbidities and therapeutic management. Results: Patients’ mean age was 56.2 ± 10.8 years, 24.6% were smokers, and most were overweight or obese. About 60% have a history of hypertension, and the majority have had diabetes for more than 10 years. Their mean HbA1c level was 8.5 ± 2%. The prevalence of hypomagnesaemia was 11% (95% CI: 8%–14.6%). It was found to be significantly higher among females (adjusted OR: 2.7, 95%CI: 1.2%–5.8%), patients with HbA1c ≥8% (adjusted OR: 2.4, 95%CI: 1.1%–5.5%) and patients with a history of diabetic retinopathy (adjusted OR: 2.7, 95%CI: 1.1%–7.1%). Conclusion: The study showed that hypomagnesaemia is more prevalent in females and is associated with diabetic retinopathy and poor glycaemic control. Having a sufficient magnesium level may be associated with better glycaemic control and a reduced occurrence of complications.

show abstract

Time to act on diabetes mellitus prevention in the West Bank, oPt: Current and future direct cost of diabetes and its complications

Cited by 4 publications

References 18 publications

The Evaluation of home medication review for patients with type 2 diabetes mellitus by community pharmacists: a randomised controlled trial

The Evaluation of home medication review for patients with type 2 diabetes mellitus by community pharmacists: a randomised controlled trial

The Magnitude, Types, and Roles of Social Support in Diabetes Management among Diabetics’ in Southern Ethiopia: a Multilevel, Multicenter Cross-Sectional Study

Hypomagnesemia and Poor Glycemic Control among Type 2 Diabetic Patients: A Cross-Sectional Study

Contact Info

Product

Resources

About